20-46126219-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001250.6(CD40):​c.498-421A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 1156 hom., cov: 18)

Consequence

CD40
NM_001250.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.725

Publications

6 publications found
Variant links:
Genes affected
CD40 (HGNC:11919): (CD40 molecule) This gene is a member of the TNF-receptor superfamily. The encoded protein is a receptor on antigen-presenting cells of the immune system and is essential for mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. AT-hook transcription factor AKNA is reported to coordinately regulate the expression of this receptor and its ligand, which may be important for homotypic cell interactions. Adaptor protein TNFR2 interacts with this receptor and serves as a mediator of the signal transduction. The interaction of this receptor and its ligand is found to be necessary for amyloid-beta-induced microglial activation, and thus is thought to be an early event in Alzheimer disease pathogenesis. Mutations affecting this gene are the cause of autosomal recessive hyper-IgM immunodeficiency type 3 (HIGM3). Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Nov 2014]
CD40 Gene-Disease associations (from GenCC):
  • hyper-IgM syndrome type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.374 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001250.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD40
NM_001250.6
MANE Select
c.498-421A>G
intron
N/ANP_001241.1
CD40
NM_001322421.2
c.498-421A>G
intron
N/ANP_001309350.1
CD40
NM_001302753.2
c.498-421A>G
intron
N/ANP_001289682.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CD40
ENST00000372285.8
TSL:1 MANE Select
c.498-421A>G
intron
N/AENSP00000361359.3
CD40
ENST00000372276.7
TSL:1
c.498-1919A>G
intron
N/AENSP00000361350.3
CD40
ENST00000466205.5
TSL:1
n.398-421A>G
intron
N/AENSP00000434825.1

Frequencies

GnomAD3 genomes
AF:
0.197
AC:
16682
AN:
84780
Hom.:
1153
Cov.:
18
show subpopulations
Gnomad AFR
AF:
0.0828
Gnomad AMI
AF:
0.363
Gnomad AMR
AF:
0.185
Gnomad ASJ
AF:
0.190
Gnomad EAS
AF:
0.385
Gnomad SAS
AF:
0.393
Gnomad FIN
AF:
0.284
Gnomad MID
AF:
0.299
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.195
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.197
AC:
16689
AN:
84850
Hom.:
1156
Cov.:
18
AF XY:
0.203
AC XY:
8273
AN XY:
40680
show subpopulations
African (AFR)
AF:
0.0830
AC:
1646
AN:
19830
American (AMR)
AF:
0.185
AC:
1411
AN:
7622
Ashkenazi Jewish (ASJ)
AF:
0.190
AC:
400
AN:
2100
East Asian (EAS)
AF:
0.385
AC:
1345
AN:
3498
South Asian (SAS)
AF:
0.393
AC:
1144
AN:
2910
European-Finnish (FIN)
AF:
0.284
AC:
1498
AN:
5272
Middle Eastern (MID)
AF:
0.306
AC:
55
AN:
180
European-Non Finnish (NFE)
AF:
0.210
AC:
8753
AN:
41696
Other (OTH)
AF:
0.194
AC:
225
AN:
1158
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
663
1326
1990
2653
3316
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
196
392
588
784
980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0829
Hom.:
148
Bravo
AF:
0.109

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.15
DANN
Benign
0.42
PhyloP100
-0.72
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6074028; hg19: chr20-44754858; API